Altimmune (ALT) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the Chairman and held virtually to increase inclusivity and participation.

• Formal business outlined in the notice and proxy statement sent to shareholders of record as of March 13, 2026.

• Directors, officers, independent auditors, and legal counsel introduced at the start.

Corporate governance

• Voting limited to shareholders of record as of March 13, 2026, with procedures for proxy and web portal voting explained.

• Quorum established with 88,270,241 shares represented out of 130,105,177 entitled to vote.

• Inspector of Election appointed to tabulate results and ensure procedural compliance.

Board and executive committee updates

• Nine nominees for director positions presented, all current directors, with no outside nominations received.

• Board unanimously recommended voting in favor of all proposals.